Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2020-03-26 2020-02-26
Drug Identification Number 02372010 02372010
Brand name JALYN JALYN
Common or Proper name dutasteride/tamsulosin hydrochloride modified release capsules dutasteride/tamsulosin hydrochloride modified release capsules
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients TAMSULOSIN HYDROCHLORIDE DUTASTERIDE TAMSULOSIN HYDROCHLORIDE DUTASTERIDE
Strength(s) 0.4MG 0.5MG 0.4MG 0.5MG
Dosage form(s) CAPSULE (IMMEDIATE AND EXTENDED RELEASE) CAPSULE (IMMEDIATE AND EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 30's 30's
ATC code G04CA G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-26 2020-02-26
Estimated end date 2020-03-31 2020-03-31
Actual end date 2020-03-25
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments